SignalCorporate
Illumina forecasts 2026 EPS of $5.40-$5.45 while raising revenue outlook to $4.64B-$4.66B
Illumina raised revenue outlook to $4.64B-$4.66B and forecast 2026 EPS of $5.40-$5.45.
Context
What happened: Illumina issued 2026 EPS guidance of $5.40 to $5.45 and raised its revenue outlook to $4.64B to $4.66B, according to its Q3 2026 earnings call.
Key numbers: 2026 EPS guidance $5.40 to $5.45; revenue outlook $4.64B to $4.66B; Q3 revenue, margin and EPS came in above the guidance range.
Why it matters: CEO Jacob Thaysen attributed the quarter to strong clinical sequencing demand and elevated NovaSeq X placements, which drove results above guidance.
Coverage: 4 outlets in 24h
What changed
Illumina issued 2026 EPS guidance of $5.40 to $5.45 and raised its revenue outlook to $4.64B to $4.66B, according to its Q3 2026 earnings call.
Why it matters
CEO Jacob Thaysen attributed the quarter to strong clinical sequencing demand and elevated NovaSeq X placements, which drove results above guidance.